BIT's 3rd International Biotechnology Congress (IBC-2019)

★ Scientific Program

Preliminary Program
Session times on those days will not be finalized until the overall program schedule is completed.

Program Tracks
(Please click each Track for detailed program information)

Opening Ceremony and Keynote Forum

Track 1: Industrial Microbiology and New Enzymes & Biocatalysis

Track 2: Novel Biomaterials

Track 3: Biomass and Bioenergy

Track 4: Environmental Biotechnology

Track 5: Green Bioprocess and Biomanufacturing

Track 5: Green Bioprocess and Biomanufacturing

Track 501: New Approaches in Upstream Bioprocessing
*Time:* 13:30-16:30, October 26, 2019 (Saturday); Place:* Singapore*
Chair	*Mr. Gilles R. Gagnon,* Chief Executive Officer, Ceapro Inc., Canada
13:30-13:35	Chair’s Introduction
13:35-13:55	*Title:* Continuous Manufacturing of Secreted Proteins in High Cell Density Perfusion Cultures of Yeast Pichia Pastors Cells *Dr. Dhinakar S. Kompala,* Founder & CEO, Sudhin Biopharma Co.,USA
13:55-14:15	*Title:* Using Different Genome Editing Approaches on the Development of the Next-generation CHO Cell Host *Dr. Mario Pereira,* Field Application Scientist, Horizon Discovery, UK
14:15-14:35	*Title:* New Tools for Genetic Stability Assessment of Production Cell and Its Transgene for Quality Assurance of Biotherapeutic Protein Products Prepared by Recombinant DNA technology *Dr. Edmund Ang,* Senior Technical Specialist, Merck BioReliance^® Services, Singapore
14:35-14:55	*Title:* The Use of High Pressure CO2 -facilitated pH Swings to Enhance in situ Product Recovery of Butyric Acid in a Two-Phase Partitioning Bioreactor *Dr. Eric Charles Peterson,* Research Fellow, Agency for Science and Technology, Singapore
14:55-15:15	Title: Metabolic Engineering of Plant Volatiles *Dr. Sarojam Rajani,* Principal Investigator, Temasek Life Sciences Laboratory, Singapore
15:15-15:30	Coffee Break
15:30-15:50	*Title:* Building Startups in Industrial Biotechnology *Dr. Joško Bobanovi,* Partner, Sofinnova Partners, France
15:50-16:10	*Title:* Ceapro Inc.: Pioneering Game Changing Technologies to Process Biomaterials *Mr. Gilles R. Gagnon,* Chief Executive Officer, Ceapro Inc., Canada
16:10-16:30	Speech Opportunity Available Abstract and Biography: Submit Here
Track 502: Pharmaceutical/Medical Biotechnology
*Time:* 13:30-17:50, October 26, 2019 (Saturday); Place:* Singapore*
Chair	*Dr. Gottfried H. Sodeck,* President, Vogelbusch GmbH, Austria
13:30-13:35	Chair’s Introduction
13:35-13:55	*Title:* The Challenging Definition of Naive Patient for Biological Drug Use *Dr. Francesco Scaglione,* Professor, Hemato-Oncology—University of Milan , Italy
13:55-14:15	*Title:* Under Preparation *Dr. Ningling Wang,* Managing Partner, Shanghai Representative Office of Finnegan, Henderson, Farabow, Garrett &Dunner, LLP, China
14:15-14:35	*Title:* Engineered Anti-PA Monoclonal Antibodies Confer Better Protection in Bacillus Anthracis pre- and post-challenge Mouse Model *Dr.* *Rajan P. Adhikari*, Assistant Director, Integrated Biotherapeutics Inc., USA
14:35-14:55	*Title:* Preclinical Study of Anti-Cancer Stem Cell Drug ACT001 and Preliminary Clinical Result in GBM therapy *Dr. Yue Chen,* Professor, Nankai University, China
14:55-15:15	*Title:* Microbial Production of 1,3-propanediol from Crude Glycerol *Dr. Gottfried H. Sodeck,* President, Vogelbusch GmbH, Austria
15:15-15:30	Coffee Break
15:30-15:50	*Title*: Protein Binders for Insoluble Fibrin Detection and Thrombus Visualization *Dr. Petr Maly,* Head of Research Group, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Czech Republic
15:50-16:10	*Title:* Development and Application of Super Flexible Heart Replicas of Congenital Heart Disease *Dr. Isao Shiraishi,* Director, National Cerebral and Cardiovascular Center, Japan
16:10-16:30	*Title:* Personalizing New Frontiers: Asia Pacific’s Precision Medicine Ms. Kristin Ciriello Pothier, Global Head of Life Sciences Strategy, EY Transaction Advisory Services, USA
16:30-16:50	*Title:* Pneumococcal Conjugate Vaccines: A Story of Medical Success *Dr. Eiman Mokaddas,* Professor of Clin ical Microbiology, Kuwait University, Kuwait
16:50-17:10	*Title:* High Throughput Assays for the Determination of the Potency and Comparability of Biosimilars and Innovator Products *Dr. Michael G Tovey,* Managing Director, Svar Life Science, France
17:10-17:30	*Title:* Drug Discovery Using Automated Synthesizer & Flow Reactor and Its Social Effect in Japan *Dr.* *Takashi Takahashi,* Professor, Yokohama University of Pharmacy, Japan
17:30-17:50	*Title:* Investigation of Interaction between Hsp70.14 and the RING Finger Domain of RBBP6 *Dr. Paul Chukwudi Ikwegbue,* University of Zululand, South Africa
Track 503: Biotechnology in Food & Agriculture
*Time:* 09:00-11:40, October 27, 2019 (Sunday); Place:* Singapore*
Chair	Dr. Igor I. Katkov, Head, Lab of the Amorphous State, Beglorod National Research University, Russia; Scientific Director, CELLTRONIX, San Diego, USA
09:00- 09:05	Chair’s Introduction
09:05-09:20	*Title:* Regulatory and Safety Requirements for Food Cultures *Dr. Anette Wind,* Senior Principal Scientist, Chr. Hansen A/S, Denmark
09:20-09:45	Title: Valorization of Silverskin, A Coffee Roasting By-product: From Laboratorial Studies to Industrial Implementation *Dr. Maria Beatriz P. P. Oliveira,* Associate, Professor with Habilitation, University of Porto, Portugal
09:45-10:05	*Title:* Using Botanical Insecticides for Insect Pest Management Control *Dr. Errol Hassan,* Adjunct Associate Professor, The University of Queensland, Australia
10:05-10:20	Coffee Break
10:20-10:40	*Title:* Perspectives on the Use of Natural Antimicrobials and Inhibitors for Food Applications: Effect of Pine Bark Extracts against Listeria monocytogenes ATCC 13932 *Dr. Joana Santos,* Professor, CISAS-Instituto Politécnico de Viana do Castelo, Portugal
10:40-11:00	*Title:* Kinetic (Hyperfast and Free of Permeable Cryoprotectants) Vitrification: A Novel Approach for Biotechnology of Husbandry Reproduction *Dr. Igor I. Katkov,* Head, Lab of the Amorphous State, Beglorod National Research University, Russia; Scientific Director, CELLTRONIX, San Diego, USA
11:00-11:20	*Title:* *International Human Biospecimen Biobanking for Precision Medicine* *Dr. Olga Potapova,* Founder and CEO, Cureline, Inc., Brisbane, CA, USA
11:20-11:40	*Title:* Genetic Manipulation of Alkaloid Biosynthesis in Plants: Use of Evolutionally Conserved Transcription Factors *Dr. Tsubasa Shoji,* Associate Professor, Nara Institute of Science and Technology, Japan

Online Registration

News Released

● The scientific program has updated
● Call for speakers, exhibitors and sponsors worldwide.
● Call for media partners and advertiser worldwide.
● Call for paper

Download

	Format of Abstract and CV
	Registration Form
	Sponsorship Application
	Conference Guide for IBC-2019

Concurrent Conference

BIT's 9^th Annual World Congress of Molecular & Cell Biology(CMCB-2019)

Hosting Organization

National Foreign Experts Databank of MOST (Dalian Branch)

Operating Organization

BIT Group Global Ltd.

Official Travel Agency

BIT World Travel Service, Inc.

Exhibitors

BIT’s Upcoming Events

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2017-2019 BIT Congress Inc.